Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome | MicrobiomeTrials← Back to trialsNCT03604198
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2018-05-07Est. Completion: 2026-12
Enrollment target: 125 participants Locations- Site 49, Phoenix, Arizona, United States
- Site 35, Stanford, California, United States
- Site 39, Torrance, California, United States
- Site 50, Miami, Florida, United States
- Site 10, Atlanta, Georgia, United States
- Site 9, Chicago, Illinois, United States
- Site 1, Indianapolis, Indiana, United States
- Site 5, Metairie, Louisiana, United States
- Site 27, Baltimore, Maryland, United States
- Site 13, Fall River, Massachusetts, United States
- Site 8, Ann Arbor, Michigan, United States
- Site 36, Rochester, Minnesota, United States
- Site 34, Jackson, Mississippi, United States
- Site 3, St Louis, Missouri, United States
- Site 55, Reno, Nevada, United States
- Site 6, Albany, New York, United States
- Site 24, New York, New York, United States
- Site 4, Wilmington, North Carolina, United States
- Site 43, Cleveland, Ohio, United States
- Site 2, Pittsburgh, Pennsylvania, United States
- Site 46, Pittsburgh, Pennsylvania, United States
- Site 11, Dallas, Texas, United States
- Site 7, El Paso, Texas, United States
- Site 32, Fort Worth, Texas, United States
- Site 12, Houston, Texas, United States
- Site 51, Nova Scotia, Canada
- Site 16, Munich, Germany
- Site 42, Würzburg, Germany
- Site 29, Tel Aviv, Israel
- Site 40, Ancona, Italy
- Site 25, Milan, Italy
- Site 21, Naples, Italy
- Site 48, Padova, Italy
- Site 33, Rotterdam, Netherlands
- Site 47, Krakow, Poland
Other microbiome trials you might be interested in
Endogenous Cushing SyndromeAdrenal InsufficiencyHypercortisolism
The major goal of this study is to determine the incidence of adrenal insufficiency in patients with endogenous Cushing …
Ann Arbor, United StatesEst. completion Oct 2027
Type 2 DiabetesCortisol Excess
CAPTAIN-T2D will take place in two parts. Part 1 (Screening) will evaluate patients with type 2 diabetes and elevated co…
Chandler, United StatesEst. completion Dec 31, 2027
Site 45, Lublin, PolandSite 37, Bucharest, RomaniaSite 31, Bucharest, RomaniaSite 28, Bucharest, RomaniaSite 53, Alicante, SpainSite 18, Girona, SpainSite 17, Madrid, SpainSite 38, Málaga, SpainSite 19, Seville, SpainHypogonadismHypergonadismPrecocious PubertyLate PubertyAmenorrhea
Background:
Endocrine disorders occur when the glands that make hormones do not work properly. Hormones levels that are…
Research Triangle Park, United StatesEst. completion Mar 28, 2039